Modification of immune response genes in various types of chronic lymphocytic leukemia
نویسندگان
چکیده
منابع مشابه
The role of microRNA in acute/chronic, myeloid/lymphocytic leukemia
MicroRNAs are small, non-coding sequences that regulate gene expression by inducing degradation or translational inhibition of target mRNAs. These molecules control many intracellular physiological and pathological processes.Abnormal expression of these moleculs has been described in different cancers including hematopoietic cancers. According to the type of cancer and the stage, miRNA’s expres...
متن کاملB Cell Chronic Lymphocytic Leukemia - A Model with Immune Response
B cell chronic lymphocytic leukemia (B-CLL) is known to have substantial clinical heterogeneity. There is no cure, but treatments allow for disease management. However, the wide range of clinical courses experienced by B-CLL patients makes prognosis and hence treatment a significant challenge. In an attempt to study disease progression across different patients via a unified yet flexible approa...
متن کاملSuppressor Genes in Chronic Lymphocytic Leukemia
B cell chronic lymphocytic leukemia (B-CLL) represents the mostfrequent adult leukemia in the Western wordL The molecular pathogenesis of B-CLL is largely unknown. Although initialreports on smaUpanels ofcases had suggested a rolefor Bcl-1 and Bcl-2 oncogene activation in B-CLL, later investigations failed to confirm these data. Among tumor suppressor genes, p53 mutations have been reported in ...
متن کاملCellular immune therapy for chronic lymphocytic leukemia.
Although chemotherapy can induce complete responses in patients with chronic lymphocytic leukemia (CLL), it is not considered curative. Treated patients generally develop recurrent disease requiring additional therapy, which can cause worsening immune dysfunction, myelosuppression, and selection for chemotherapy-resistant leukemia-cell subclones. Cellular immune therapy promises to mitigate the...
متن کاملInfusion of isologous immune plasma in chronic lymphocytic leukemia.
T HE USE OF ANTILYMPHOCYTE serum for the treatment of leukemia has been explored intermittently during the past forty years. In 1927 Lindstrom1 concluded that antiserum was approximately as effective as the method of radiation therapy then in use. Most of the early studies were conducted using hetero-antisera, such as those now being used, to suppress the response to transplanted tissues. From ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Scientific Notes of the I. P. Pavlov St. Petersburg State Medical University
سال: 2015
ISSN: 2541-8807,1607-4181
DOI: 10.24884/1607-4181-2015-22-1-21-24